Improving Lifejacket Wear Among Boaters on Lake Albert, Uganda

Status Recruiting

Clinical Trial Summary

A cluster randomized trial will be conducted for six months. To avoid covariate imbalance at baseline, stratified permuted block randomization with a 1:1 allocation ratio will be done. At least 387 boaters across 7 clusters per arm will be interviewed post baseline to give a 90% power to detect the effect of the intervention if such effect exists. A mixed effects multi-level modeling at 5% alpha level will be done using logical model building procedures

Clinical Trial Description

Given that the intervention will be at the community level, a cluster randomized controlled trial is considered most appropriate for testing the hypothesis of this study. The intact groups/clusters of individuals (boaters) rather than individuals themselves, will be randomized to either intervention or control arm. The landing sites herein referred to as clusters, will be the randomization unit. This is because it is difficult to randomize individuals to behavioral intervention since they mix within the cluster. This study will be conducted using an etic epistemological approach guided by a realist ontology in order to objectively measure the effect of the intervention without the influence of the researchers. To reduce covariate imbalance and increase comparability at baseline, clusters will be randomized to either intervention or control arm using stratified permuted block randomization, with landing sites (clusters) as the randomization unit. The clusters will be stratified by estimated population size and baseline prevalence of lifejacket use as compared with the overall average prevalence. All individuals in the intervention cluster will receive the intervention. The main aim of the stratified randomization is to ensure that the clusters are as comparable as possible at baseline. The other factors that might be considered for stratification will be identified at baseline and, in the opinion of the investigator, might interfere with the objectives of the study. Because there are few clusters per arm (7), two strata will be formed. The stratification variable will be the baseline prevalence of lifejacket wear in the landing sites. The risk of contamination (one of the major threats to this study) will be reduced by ensuring that at least one cluster which is not part of the study acts as a buffer. From each stratum, one cluster will be randomly allocated to the intervention arm and the other to the control arm using stratified permuted block randomization with a 1:1 allocation ratio. The allocation will be generated using the 'sealed envelope TM' web-based application by an independent statistician who has no interest in the study. The block sizes will be masked/blinded to increase the randomness. ;

Study Design

Related Conditions & MeSH terms

Drowning

Clinical Trial Details

NCT number	NCT05337761
Study type	Interventional
Source	Makerere University
Contact	Frederick Oporia, MPH
Phone	+256703857428
Email	foporia@musph.ac.ug
Status	Recruiting
Phase	N/A
Start date	April 25, 2022
Completion date	October 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05977530` - Teaching Young Children Swim Survival Skills	N/A
Recruiting	`NCT03498963` - Pathogens Responsible for Respiratory Infections Associated With Drowning in Seawater	N/A
Completed	`NCT05908630` - Accidental Hypothermia in Drowning-related OHCA
Not yet recruiting	`NCT06327893` - Patients Treated by the Danish Emergency Medical Services Following Non-drowning Water Rescues From 2016 to 2023
Not yet recruiting	`NCT06312202` - Drowning Incidents in Danish Harbours
Not yet recruiting	`NCT06310486` - The Emergency Call on Drowning
Completed	`NCT00341289` - Environmental and Behavioral Risk Factors for Childhood Drowning	N/A
Active, not recruiting	`NCT06322134` - Drowning Incidents Treated by the Danish SAR Helicopters
Completed	`NCT04250532` - Pulse Oximetry in Healthy SubjEcts ImmergeD in OceaN.
Completed	`NCT05751655` - Observational Study of Drowning Patient's Emergency Care in Its Pre-hospital Phase.
Not yet recruiting	`NCT06334276` - Developing an Utstein-style Danish Drowning Registry: Nationwide Fatal and Nonfatal Drowning Data Since 2016
Active, not recruiting	`NCT06310525` - Using Machine Learning to Optimise the Danish Drowning Formula
Recruiting	`NCT06320197` - In Situ Simulation Training in Lifeguard Organisations
Completed	`NCT05425537` - Drowning in Denmark: A Six-year Registry-based Study of Fatal and Non-fatal Drowning
Completed	`NCT05323097` - Drowning-related OHCA in Denmark: A Six-year Registry-based Study
Not yet recruiting	`NCT06310499` - Primary or Secondary Drowning
Not yet recruiting	`NCT06183827` - Drowning-related Acute Respiratory Failure	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.